Psychokardiologie: praxisrelevante Erkenntnisse und Handlungsempfehlungen

Zusammenfassung

Psychosoziale Risikofaktoren (Arbeitsstress, niedrige Sozialschicht, mangelnde soziale Unterstützung, Ärger, Angst, Depressivität), überdauernde Persönlichkeitsmuster (z. B. Feindseligkeit) sowie die posttraumatische Belastungsstörung können die Entwicklung und den Verlauf zahlreicher Herz-Kreislauf-Erkrankungen negativ beeinflussen. Eine systematische Erfassung dieser Faktoren hilft, das Risiko angemessen einzuschätzen und bei der Behandlung zu berücksichtigen. Die vorgestellten Behandlungsempfehlungen stützen sich auf aktuelle Positionspapiere und Leitlinien.

Der Arzt-Patienten-Kontakt sollte grundsätzlich nach den Prinzipien einer patientenzentrierten Kommunikation erfolgen und alters- sowie geschlechtsspezifische Besonderheiten berücksichtigen. Die psychosomatische Grundversorgung ist eine wirksame, niedrigschwellige Option zur Behandlung psychosozialer Risikofaktoren und sollte regelmäßig angeboten werden.

Bluthochdruckpatienten können (allerdings mit mäßigem Effekt) von Entspannungsverfahren oder Biofeedback profitieren. Patienten mit koronarer Herzerkrankung, Herzinsuffizienz oder nach Herzoperationen soll ein individuell angepasstes, multimodales Behandlungskonzept angeboten werden, das Wissensvermittlung, Sport- und Bewegungstherapie, Motivationsförderung, Entspannungsverfahren und Stressmanagement umfasst. Bei einer psychischen Komorbidität ist oft zusätzlich eine psychotherapeutische Behandlung indiziert. Eine antidepressive Pharmakotherapie sollte bei einer mindestens mittelschweren depressiven Störung angeboten werden, wobei bevorzugt selektiven Serotonin-Wiederaufnahme-Hemmer (SSRI) eingesetzt werden sollten. Psychotherapie und SSRI, insbesondere Sertralin, sind bei bestimmungsgemäßem Gebrauch sicher und wirksam hinsichtlich einer Verbesserung der Lebensqualität. Eine Prognoseverbesserung ist nicht eindeutig belegt. Patienten mit implantiertem Defibrillator sollten im Rahmen der psychosomatischen Grundversorgung, bei psychischer Komorbidität mit Psychotherapie und ggf. auch SSRI, behandelt werden. Trizyklische Antidepressiva sollten wegen unerwünschter kardialer Wirkungen bei Herzpatienten möglichst vermieden werden.

Abstract

Psychosocial risk factors (work stress, low socioeconomic status, impaired social support, anger, anxiety and depression), certain personality traits (e. g. hostility) and post-traumatic stress disorders may negatively influence the incidence and course of multiple cardiovascular disease conditions. Systematic screening for these factors may help to adequately assess the psychosocial risk pattern of a given patient and may also contribute to the treatment of these patients. Recommendations for treatment are based on current guidelines.

The physician-patient interaction should basically follow the principle of a patient centered communication and should gender and age specific aspects into consideration. Integrated biopsychosocial care is an effective, low threshold option to treat psycho-social risk factors and should be offered on a regular basis.

Patients with high blood pressure may profit from relaxation programs and biofeedback procedures (however with moderate success). An individually adjusted multimodal treatment strategy should be offered to patients with coronary heart disease, heart failure and after heart surgery. It may incorporate educational tools, exercise therapy, motivational modules, relaxation and stress management programs. In case of affective comorbidity, psychotherapy may be indicated. Anti-depressant pharmacotherapy with selective serotonin reuptake inhibitors (SSRIs) in the first line should only be offered to patients with at least moderate severe depressive episodes. Psychotherapy and SSRIs, particularly sertraline, have been proven to be safe and effective with regard to improvements of the patient’s quality of life. A prognostic benefit has not been clearly proven so far. Patients with an implanted cardioverter/defibrillator (ICD) should receive psychosocial support on a regular basis. Concomitant psychotherapy and/or psychopharmacotherapy (SSRIs) should be offered in case of a severe mental comorbidity. Generally, tricyclic antidepressants should be avoided in cardiac patients because of adverse side effects.

Schlüsselwörter

Herz-Kreislauf-Erkrankungen - psychosoziale Risikofaktoren - Depression - Angst - Psychotherapie - Psychopharmakotherapie

Keywords

cardiovascular disorders - psychosocial risk factors - depression - anxiety - psychotherapy - pharmacotherapy

• Literatur

• 1 Abouzeid M, Kelsall HL, Forbes AB. Posttraumatic stress disorder and hypertension in Australian veterans of the 1991 Gulf War. J Psychosom Res 2012; 72: 33-38
• 2 Albus C, Jordan J, Herrmann-Lingen C. Screening for psychosocial risk factors in patients with coronary heart disease – recommendations for clinical practice. Eur J Cardiov Prev R 2004; 11: 75-79
• 3 Barth J, Schneider S, van Känel R. Lack of social support in the etiology and the prognosis of coronary heart disease. Psychosom Med 2010; 72: 229-238
• 4 Baumeister H, Hutter N, Bengel J. Psychological and pharmacological interventions for depression in patients with coronary artery disease. Cochrane Database Syst Rev 2011; 9 CD008012
• 5 Braunschweig F, Boriani G, Bauer A et al. Management of patients receiving implantable cardiac defibrillator shocks: recommendations for acute and long-term patient management. Europace 2010; 12: 1673-1690
• 6 Bundesärztekammer, Kassenärztliche Bundesvereinigung, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften. Nationale VersorgungsLeitlinie Chronische Herzinsuffizienz. Langfassung. 2012; Version 1.5
• 7 Chida Y, Steptoe A. The association of anger and hostility with future coronary heart disease: a meta-analytic review of prospective evidence. J Am Coll Cardiol 2009; 53: 936-946
• 8 Clark AM, Hartling L, Vandermeer B et al. Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med 2005; 143: 659-672
• 9 Davidson KW, Bigger JT, Burg MM et al. Centralized, stepped, patient preference-based treatment for patients with post-acute coronary syndrome depression: CODIACS vanguard randomized controlled trial. JAMA Intern Med 2013; 173: 997-1004
• 10 Dew MA, Kormos RL, Roth LH. Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. J Heart Lung Transplant 1999; 18: 549-562
• 11 DGPPN, BÄK, KBV. S3-Leitlinie/Nationale Versorgungsleitlinie Unipolare Depression – Langfassung. 2009
• 12 Dickinson H, Campbell F, Beyer F. Relaxation therapies for the management of primary hypertension in adults. Cochrane Database Syst Rev 2008; 23 CD004935
• 13 Dickstein KA, Cohen-Solal A, Filippatos G et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J 2008; 29: 2388-2442
• 14 Eaker ED, Sullivan LM, Kelly-Hayes M et al. Tension and anxiety and the prediction of the 10-year incidence of coronary heart disease, atrial fibrillation, and total mortality: the Framingham Offspring Study. Psychosom Med 2005; 67: 692-696
• 15 Edmondson D, Kronish IM, Shaffer JA et al. Posttraumatic stress disorder and risk for coronary heart disease. Am Heart J 2013; 166: 806-814
• 16 Faller H, Storck S, Schuler M. Depression and Disease Severity as Predictors of Health-Related Quality of Life in Patients With Chronic Heart Failure. J Card Fail 2009; 15: 286-292
• 17 Finset A. Research on person-centered clinical care. J Eval Clin Pract 2011; 17: 384-386
• 18 Gohlke H, Albus C, Bönner G et al. Empfehlungen der Projektgruppe Prävention der DGK zur risikoadjustierten Prävention von Herz-Kreislauferkrankungen. Teil 4: Thrombozytenfunktionshemmer, Hormonersatztherapie, Verhaltensänderung und psychosoziale Risikofaktoren. Kardiologe 2013; 7: 297-306
• 19 Grande G, Romppel M, Barth J. Association between type D personality and prognosis in patients with cardiovascular diseases. Ann Behav Med 2012; 43: 299-310
• 20 Gulliksson M, Burell G, Vessby B et al. Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: Secondary Prevention in Uppsala Primary Health Care project (SUPRIM). Arch Intern Med 2011; 17: 134-140
• 21 Havik OE, Sivertsen B, Relbo A. Depressive symptoms and all-cause mortality after heart transplantation. Transplantation 2007; 84: 97-103
• 22 Hawkes AL, Nowak M, Bidstrup B et al. Outcomes of coronary artery bypass graft surgery. Vasc Health Risk Manag 2006; 2: 477-484
• 23 Heilmann C, Kuijpers N, Beyeersdorf F et al. Supportive psychotherapy for ptients with heart transppntation or ventricular assist devices. Eur J cardio thoracic surg 2011; 39: e44-e50
• 24 Herrmann-Lingen C, Buss U. Angst und Depressivität im Verlauf der koronaren Herzkrankheit. Reihe „Statuskonferenz Psychokardiologie“. Hrsg.: Jordan J, Bardé B, Zeiher AM. Band 5. Frankfurt: VAS; 2002
• 25 Herrmann-Lingen C. Psychosomatik der Herzinsuffizienz. Alles nur Depression?. Herz 2011; 36: 135-140
• 26 Hillis LD, Smith PK, Anderson JL et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. Circulation 2011; 124: e652-735
• 27 Juenger J, Schellberg D, Kraemer S. Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart 2002; 87: 235-241
• 28 Köllner V, Einsle F, Schade I. Psychosoziale Belastung und Lebensqualität bei Patienten nach Herz- oder Lungentransplantation. Z Psychosomat Med Psychother 2003; 49: 262-274
• 29 Ladwig KH, Baumert J, Marten-Mittag B. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study. Arch Gen Psychiatry 2008; 65: 1324-1330
• 30 Ladwig KH, Gärtner C, Walz L. The inner barrier: how health psychology concepts contribute to the explanation of prehospital delays in acute myocardial infarction. Psychother Psychosom Med Psychol 2009; 59: 5
• 31 Ladwig KH, Lederbogen F, Albus C et al. Positionspapier zur Bedeutung von psychosozialen Faktoren in der Kardiologie. Update 2013. Kardiologe 2013; 7: 7-27
• 32 Lange HW, Herrmann-Lingen C. Depressive symptoms predict recurrence of atrial fibrillation after cardioversion. J Psychosom Res 2007; 63: 509-513
• 33 Linden W, Moseley J. The efficacy of behavioral treatments for hypertension. Appl Psychophysiol Biofeedback 2006; 31: 51-63
• 34 Low CA, Thurston RC, Matthews KA. Psychosocial factors in the development of heart disease in women: current research and future directions. Psychosom Med 2010; 72: 842-854
• 35 Magyar-Russell G, Thombs BD, Cai JX. The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review. J Psychosom Res 2011; 71: 223-231
• 36 McAlister F, Lawson F, Teo K. A systematic review of randomized trials of disease management programs in heart failure. Am J Med 2001; 110: 378-384
• 37 McCabe PJ. Psychological distress in patients diagnosed with atrial fibrillation: the state of the science. J Cardiovasc Nurs 2010; 25: 40-51
• 38 Mostofsky E, Maclure M, Sherwood JB. Risk of acute myocardial infarction after the death of a significant person in one's life. Circulation 2012; 125: 491-496
• 39 Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146538 participants in 54 observational studies. Eur Heart J 2006; 27: 2763-2774
• 40 O'Connor CM, Jiang W, Kuchibhatla M. Safety and efficacy of sertraline for depression in patients with heart failure. JACC 2010; 56: 692-699
• 41 Orth-Gomér K, Schneiderman N, Wang HX et al. Stress reduction prolongs life in women with coronary disease: the Stockholm Women's Intervention Trial for Coronary Heart Disease (SWITCHD). Circ Cardiovasc Qual Outcomes 2009; 2: 25-32
• 42 Perk J, De Backer G, Gohlke H et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur Heart J 2012; 33: 1635-1701
• 43 Richardson S, Shaffer JA, Falzon L et al. Meta-analysis of perceived stress and its association with incident coronary heart disease. Am J Cardiol 2012; 110: 1711-1716
• 44 Roest AM, Martens EJ, de Jonge P. Anxiety and risk of incident coronary heart disease. J Am Coll Cardiol 2010; 56: 38-46
• 45 Roest AM, Martens EJ, Denollet J. Prognostic association of anxiety following myocardial infarction with mortality and new cardiac events. Psychosom Med 2010; 72: 563-569
• 46 Rozanski A, Blumenthal JA, Davidson KW et al. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol 2005; 45: 637-651
• 47 Rutledge T, Redwine LS, Linke SE et al. A meta-analysis of mental health treatments and cardiac rehabilitation for improving clinical outcomes and depression among patients with coronary heart disease. Psychosom Med 2013; 75: 335-349
• 48 Rutledge T, Reis VA, Linke SE. Depression in heart failure. JACC 2006; 48: 1527-1537
• 49 Selnes OA, McKhann GM, Borowicz LM et al. Cognitive and neurobehavioral dysfunction after cardiac bypass procedures. Neurol Clin 2006; 24: 133-145
• 50 Sparrenberger F, Cichelero FT, Ascoli AM. Does psychosocial stress cause hypertension? A systematic review of observational studies. J Hum Hypertens 2009; 23: 12-19
• 51 Stringhini S, Sabia S, Shipley M. Association of socioeconomic position with health behaviors and mortality. JAMA 2010; 303: 1159-1166
• 52 Thombs BD, Bass EB, Ford DE. Prevalence of depression in survivors of acute myocardial infarction. Review of the evidence. J Gen Intern Med 2006; 21: 30-38
• 53 Thrall G, Lane D, Carroll D. Quality of life in patients with atrial fibrillation. Am J Med 2006; 119: e1-19
• 54 Tofler GH, Muller JE. Triggering of acute cardiovascular disease and potential preventive strategies. Circulation 2006; 114: 1863-1872
• 55 Tzeis S, Kolb C, Baumert J. Effect of depression on mortality in implantable cardioverter defibrillator recipients-findings from the prospective LICAD study. Pacing Clin Electrophysiol 2011; 34: 991-7
• 56 Virtanen M, Ferrie JE, Singh-Manoux A. Overtime work and incident coronary heart disease. Eur Heart J 2010; 31: 1737-1744
• 57 Wang Q, Xi B, Liu M. Short sleep duration is associated with hypertension risk among adults: a systematic review and meta-analysis. Hypertens Res 2012; 35: 1012-1018
• 58 Wenzel-Seifert K, Wittmann M, Haen E. QTc prolongation by psychotropic drugs and the risk of Torsade de Pointes. Dtsch Arztebl Int 2011; 108: 687-693
• 59 Whalley B, Rees K, Davies P. Psychological interventions for coronary heart disease. Cochrane Database Syst Rev 2011; CD002902
• 60 Whang W, Albert C, Sears SF. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators. J Am Coll Cardiol 2005; 45: 1090-1095
• 61 Wilbert-Lampen U, Leistner D, Greven S. Cardiovascular events during World Cup soccer. N Engl J Med 2008; 358: 475-483
• 62 Zipfel S, Schneider A, Wild B. Effect of depressive symptoms on survival after heart transplantation. Psychosom Med 2002; 64: 740-747